- Medical College of Pennsylvania, Philadelphia
Internship / Residency
- Internal Medicine - Medical College of Pennsylvania
- American Board of Internal Medicine
Dr. Anthony Perre, Chief of the Division of Outpatient Medicine at Cancer Treatment Centers of America® (CTCA) and Director of New Patient Intake and Vice Chief of Staff at CTCA® in Philadelphia, is committed to putting patients first. He believes it is critical to listen and respond to patients' needs on all levels—physical, emotional and/or spiritual. In addition, he strongly feels that patients should be treated with the compassion and dignity they deserve.
Dr. Perre fully understands what it’s like to be in the patient’s shoes—he himself is a Hodgkin lymphoma survivor. He says, “I understand that it is extremely frightening to consider that there may be a potential impediment to realizing future hopes and dreams. The uncertainty of what the future will bring can also be overwhelming.”
In May 2010, Dr. Perre became our Philadelphia hospital's Director of New Patient Intake. Previously, he served as Chief of Medicine and lead hospitalist at the hospital. In this role, Dr. Perre directed, coordinated and managed the general medical care of hospitalized patients. He explains that this involved managing patients’ blood glucose levels, hypertension or more complex cardiovascular, pulmonary, renal or gastrointestinal issues. Furthermore, Dr. Perre also helped to identify barriers to a patient’s recovery. He worked with members of the patient’s care team (e.g., oncologist, nutritionist, physical therapist, naturopathic clinician, spiritual advisor) to address any problems.
Prior to joining CTCA, Dr. Perre practiced both outpatient and inpatient hospital medicine for nine years, serving the community of Doylestown, Pennsylvania at Doylestown Hospital.
Dr. Perre has a special interest in diabetic management, survivorship planning and venous thromboembolic disease (blood clots). While at Doylestown Hospital, he served as a member of the Diabetic Control Committee, overseeing protocols for improved management of blood sugars for hospitalized patients. He also served as a chairman of the hospital’s Infection Control Committee. As chairman of this committee, Dr. Perre instituted practices to reduce the incidence of hospital-acquired infections.
A native of Philadelphia, Dr. Perre graduated from medical school at the Medical College of Pennsylvania (now known as Drexel University’s College of Medicine), where he also completed an internship and residency, serving as Chief Resident.
Dr. Perre is board certified and has been recognized by Philadelphia magazine and Delaware Valley Consumers’ CHECKBOOK as a “Top Doctor” in internal medicine. In addition, he was recognized as one of Castle Connolly's Top Doctors® in 2013, and in 2017 was recognized as a Philadelphia Magazine Top Docs™ award winner in Internal Medicine.
Dr. Perre belongs to several professional organizations, including the Pennsylvania Medical Society, the American College of Physicians and the Alpha Omega Alpha Honor Medical Society.
Patient ratings and comments
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.